Some evidence suggests that all RTN proteins (RTN1-RTN4) and receptor NgR are engaged in the pathology of AD by regulating the beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) function or APP processing, and thereby amyloid β production in the brain [17]. This evidence concerns the gene APP and Alzheimer disease.